Abstract
OBJECTIVES: The authors report their experience on the use of a high number of biopsies for the diagnosis of a vesicourethral anastomosis tumor recurrence in patients who underwent radical prostatectomy with a PSA elevation. METHODS: Sixty-five patients with PSA > or = 0.4 ng/ml after radical prostatectomy received 6 to 8 transrectal ultrasound (TRUS) guided biopsies of the vesicourethral anastomosis. RESULTS: The biopsy scheme with 6 random anastomotic biopsies plus additional biopsies through TRUS detectable lesions was able to diagnose a local recurrence in more than 60% of the cases. In presence of a post-operative PSA <1.0 ng/ml and in absence of ultrasound detectable or palpable lesions a local neoplastic recurrence was detected in 58% of the cases. In presence of a palpable or ultrasound visible lesions, the detection rate increases to 80% of the cases.
| Original language | Italian |
|---|---|
| Pages (from-to) | 129-131 |
| Number of pages | 3 |
| Journal | Archivio Italiano di Urologia e Andrologia |
| Volume | 74 |
| Issue number | 3 |
| Publication status | Published - Sep 2002 |
Fingerprint
ASJC Scopus subject areas
- Nephrology
- Urology
Cite this
Il ruolo diagnostico delle biopsie eco-guidate della anastomosi vescico-uretrale nei pazienti con un aumento del PSA (> or = 0,4 ng/ml) dopo prostatectomia radicale. / Scattoni, Vincenzo; Roscigno, Marco; Raber, Marco; Montorsi, Francesco; Bertini, Roberto; Bua, Lina; Da Pozzo, Luigi; Rigatti, Patrizio.
In: Archivio Italiano di Urologia e Andrologia, Vol. 74, No. 3, 09.2002, p. 129-131.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Il ruolo diagnostico delle biopsie eco-guidate della anastomosi vescico-uretrale nei pazienti con un aumento del PSA (> or = 0,4 ng/ml) dopo prostatectomia radicale.
AU - Scattoni, Vincenzo
AU - Roscigno, Marco
AU - Raber, Marco
AU - Montorsi, Francesco
AU - Bertini, Roberto
AU - Bua, Lina
AU - Da Pozzo, Luigi
AU - Rigatti, Patrizio
PY - 2002/9
Y1 - 2002/9
N2 - OBJECTIVES: The authors report their experience on the use of a high number of biopsies for the diagnosis of a vesicourethral anastomosis tumor recurrence in patients who underwent radical prostatectomy with a PSA elevation. METHODS: Sixty-five patients with PSA > or = 0.4 ng/ml after radical prostatectomy received 6 to 8 transrectal ultrasound (TRUS) guided biopsies of the vesicourethral anastomosis. RESULTS: The biopsy scheme with 6 random anastomotic biopsies plus additional biopsies through TRUS detectable lesions was able to diagnose a local recurrence in more than 60% of the cases. In presence of a post-operative PSA <1.0 ng/ml and in absence of ultrasound detectable or palpable lesions a local neoplastic recurrence was detected in 58% of the cases. In presence of a palpable or ultrasound visible lesions, the detection rate increases to 80% of the cases.
AB - OBJECTIVES: The authors report their experience on the use of a high number of biopsies for the diagnosis of a vesicourethral anastomosis tumor recurrence in patients who underwent radical prostatectomy with a PSA elevation. METHODS: Sixty-five patients with PSA > or = 0.4 ng/ml after radical prostatectomy received 6 to 8 transrectal ultrasound (TRUS) guided biopsies of the vesicourethral anastomosis. RESULTS: The biopsy scheme with 6 random anastomotic biopsies plus additional biopsies through TRUS detectable lesions was able to diagnose a local recurrence in more than 60% of the cases. In presence of a post-operative PSA <1.0 ng/ml and in absence of ultrasound detectable or palpable lesions a local neoplastic recurrence was detected in 58% of the cases. In presence of a palpable or ultrasound visible lesions, the detection rate increases to 80% of the cases.
UR - http://www.scopus.com/inward/record.url?scp=0036719864&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036719864&partnerID=8YFLogxK
M3 - Articolo
C2 - 12416005
AN - SCOPUS:0036719864
VL - 74
SP - 129
EP - 131
JO - Archivio Italiano di Urologia Nefrologia Andrologia
JF - Archivio Italiano di Urologia Nefrologia Andrologia
SN - 1120-8538
IS - 3
ER -